Ligand Pharmaceuticals In shares owned by UBS Group
Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Ligand Pharmaceuticals In
Tip: Access up to 7 years of quarterly data
All positions including Ligand Pharmaceuticals In held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ligand Pharmaceuticals In by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.4M | 19k | 71.42 |
| 2023-09-30 | $414k | 6.9k | 59.91 |
| 2023-06-30 | $582k | 8.1k | 72.10 |
| 2023-03-31 | $87k | 1.2k | 73.56 |
| 2022-12-31 | $111k | 1.7k | 66.80 |
| 2022-09-30 | $31k | 360 | 86.11 |
| 2022-06-30 | $60k | 670 | 89.74 |
| 2022-03-31 | $3.5M | 31k | 112.64 |
| 2021-12-31 | $4.1M | 27k | 154.32 |
| 2021-09-30 | $3.7M | 27k | 139.16 |
| 2021-06-30 | $2.4M | 19k | 131.14 |
| 2021-03-31 | $15M | 96k | 152.45 |
| 2020-12-31 | $3.8M | 39k | 99.16 |
| 2020-09-30 | $956k | 10k | 95.36 |
| 2020-06-30 | $848k | 7.6k | 111.87 |
| 2020-03-31 | $1.1M | 15k | 72.76 |
| 2019-12-31 | $7.6M | 73k | 104.33 |
| 2019-09-30 | $6.6M | 67k | 99.52 |
| 2019-06-30 | $1.3M | 11k | 114.18 |
| 2019-03-31 | $4.4M | 35k | 125.73 |
| 2018-12-31 | $6.3M | 46k | 135.66 |
| 2018-09-30 | $11M | 39k | 274.47 |
| 2018-06-30 | $4.1M | 20k | 207.13 |
| 2018-03-31 | $10M | 62k | 165.15 |
| 2017-12-31 | $1.5M | 11k | 137.12 |
| 2017-09-30 | $3.7M | 27k | 136.17 |
| 2017-06-30 | $4.7M | 39k | 121.40 |
| 2017-03-31 | $2.0M | 19k | 105.88 |
| 2016-12-31 | $5.7M | 57k | 101.61 |
| 2016-09-30 | $2.9M | 29k | 102.07 |
| 2016-06-30 | $5.6M | 47k | 120.00 |
| 2016-03-31 | $1.3M | 12k | 106.67 |
| 2015-12-31 | $7.2M | 67k | 108.42 |
| 2015-09-30 | $2.8M | 33k | 85.67 |
| 2015-03-31 | $1.8M | 23k | 76.67 |